Blair William & CO Biodesix Inc Transaction History

Blair William & CO

$33.4 Billion
Q3 2024

A detailed history of Blair William & CO transactions in Biodesix Inc stock. As of the latest transaction made, Blair William & CO holds 83,400 shares of BDSX stock, worth $120,930. This represents 0.0% of its overall portfolio holdings.

Number of Shares

83,400

Previous 83,400 -0.0%

Holding current value

$120,930

Previous $127,000 16.54%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$1.21 - $1.71 $4,356 - $6,156	3,600 Added 4.51%	83,400 $127,000
Q1 2024 May 09, 2024	SELL	$1.35 - $2.12 $13,500 - $21,200	-10,000 Reduced 11.14%	79,800 $114,000
Q4 2023 Feb 12, 2024	BUY	$1.2 - $2.13 $12,000 - $21,300	10,000 Added 12.53%	89,800 $165,000
Q3 2023 Nov 09, 2023	BUY	$1.04 - $1.74 $5,200 - $8,700	5,000 Added 6.68%	79,800 $131,000
Q2 2023 Aug 11, 2023	BUY	$1.12 - $1.88 $28,000 - $47,000	25,000 Added 50.2%	74,800 $92,000
Q1 2023 May 12, 2023	BUY	$1.52 - $2.5 $45,600 - $75,000	30,000 Added 151.52%	49,800 $92,000
Q4 2022 Feb 10, 2023	BUY	$0.98 - $2.3 $19,404 - $45,540	19,800 New	19,800 $45,000
Q2 2022 Aug 10, 2022	SELL	$1.32 - $2.12 $46,770 - $75,115	-35,432 Reduced 76.64%	10,800 $18,000
Q1 2022 May 13, 2022	BUY	$1.69 - $5.81 $8,754 - $30,095	5,180 Added 12.62%	46,232 $78,000
Q4 2021 Feb 14, 2022	SELL	$4.09 - $8.67 $940 - $1,994	-230 Reduced 0.56%	41,052 $217,000
Q3 2021 Nov 12, 2021	SELL	$6.6 - $12.78 $322,858 - $625,172	-48,918 Reduced 54.23%	41,282 $339,000
Q2 2021 Aug 12, 2021	BUY	$12.14 - $20.35 $296,677 - $497,313	24,438 Added 37.16%	90,200 $1.19 Million
Q1 2021 May 13, 2021	BUY	$16.87 - $31.21 $831,049 - $1.54 Million	49,262 Added 298.56%	65,762 $1.34 Million
Q4 2020 Feb 09, 2021	BUY	$10.89 - $20.16 $179,685 - $332,640	16,500 New	16,500 $333,000

Others Institutions Holding BDSX

# of Institutions

Shares Held

62.3M

Call Options Held

2.6K

Put Options Held

10.1K

View Full List

About BIODESIX INC

Ticker BDSX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 39,982,000
Market Cap $58M
Description
Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...

More about BDSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account